Ironwood Pharmaceuticals | IRWD - Zinsaufwendungen Für Schuld

Aktienkurs
4.04
Täglich Wechseln
0.39 10.68%
Monatlich
19.88%
Jährlich
459.40%
Q2 Prognose
3.53




Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Akebia Therapeutics 4.83M 359.32M 2025-12
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amarin USD 3K 5K 2024-12
Ardelyx USD 5.76M 37K 2025-12
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Charles River Laboratories USD 23.78M 1.63M 2025-12
Coherus Biosciences USD 2.25M 76K 2025-12
Esperion Therapeutics USD 22.64M 585K 2025-12
Halozyme Therapeutics USD 4.91M 615K 2025-12
Incyte USD 582K 10K 2025-12
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
MacroGenics USD 3.34M 2.54M 2025-09
Moderna USD 12.14B 12.13B 2025-09
Myriad Genetics USD 4.4M 600K 2025-12
Pacira USD 3.89M 387K 2025-12
PTC Therapeutics USD 50.58M 2.59B 2025-12
Puma Biotechnology USD 3.37M 11K 2024-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Takeda JPY 123.63B 40.49B 2025-12
Ultragenyx Pharmaceutical USD 19M 4.85M 2025-12
Vanda Pharmaceuticals 601.14M 23.61M 2025-09